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Abstract: Cavernous malformations (cavernomas) are congenital low flow angiographic 
occult vascular lesions with a high tencency to bleeding. The prevalence of cerebral 
cavernous vascular malformations is estimated to be 0.4% to 0.9%.2,7 CMs in deep 
locations, including the brainstem, thalamus, and basal ganglia, account for 9% to 35% 
of all malformations in the brain. We performed a retrospective 10 years study on 130 
operated cerebral cavernomas and discussed the clinical status at presentation, the choice 
and timing of the surgical approach and the short and longterm follow up. The 130 
operated cases were divided into a supratentorial 102 (78.46%) group and an 
infratantorial group 28 (21.53%). The average age at presentation was 43,62 years old 
(17-76) and there was no sex predominance, male/female = 1,44 (77/53). Only in 14 cases 
(10.76%) we could find multiple cavernomas which had relatives with multiple 
cavrnomas, but the familial inheritance was not studied, and only the symptomatic lesion 
was resected. We divided the outcome results reporting for agroup with superficial 
respectively profound lesions. The long term follow up for the patients in the profound 
lesions group showed that 31/37 (83,78%) of patients had a mRS between 0 and 2, and 
the rest had a poor long term outcome. After surgery there was no clinical deterioration 
in the superficial lesions group and 22 patients from those who presented in mRS 2 
showed neurological improvement on long term follow up, meaning that 82,79% of 
patients had a 0 or 1 mRS. Microsurgery is the treatment of choice in symptomatic brain 
cavernomas, total resection being the only curative treatment, capable to prevent further 
bleeding and to offer an efficient control of seizures.  
Key words: cavernous malformation, microneurosurgery, seizures. 
 
Introduction 
Cavernous malformations (cavernomas) 
are congenital low flow vascular lesions, which 
can be associated with other lesions from the 
same spectrum like capillary telangiectasias 
and developmental venous anomalies, they 
account for 1% of intracranial vascular lesions 
an d 15% of vascular malformations. (1, 6) The 
prevalence of cerebral cavernous vascular 
malformations is estimated to be 0.4% to 0.9% 
(2, 7). Malformations in deep locations 
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including the brainstem, thalamus, and basal 
ganglia are of particular interest because their 
critical location renders them very challenging 
for surgical resection (3, 7, 10). Cavernomas 
are well circumscribed, benign, low-flow 
vascular malformations, composed of 
irregular sinusoidal vascular channels, lacking 
smooth muscle and elastic fibers.  
They lack feeding arteries or draining veins 
and contain no neural tissue. By comparison  
to other vascular malformations included  in 
McCormick classification (1966), angiography 
is not a good  diagnostic  tool as there is no 
blood  flow  inside  these  lesions, yet their 
characteristic mulberry shape on MRI directs 
the  diagnostic. (8, 9, 10) 
Though the mechanism of growth of these 
lesions was not completely elucidated most 
studies sugest that repeated subclinical 
bleeding episodes inside the lesion and the 
subsequent thrombus formation and 
trombolisis create the “caverne” that give the 
name and the typical mulberry appearance on 
T2 MRI. (5) 
After Rigamonti’s first description of this 
aspect in 1986, Zabramsky developed a 4 grade 
classification of cavernous malformations 
based on MRI, in which grade 1are 
hyperintense grade II are both hyper and 
hypointense,  grade III are hypointense and 
grade IV are small “black spot lesions” visible 
only on gradient echo these were considered 
capillary telangiectasies. (21, 25)      
CMin deep locations is not completely 
understood, but most reports suggest that they 
have a higher rate of hemorrhage than 
superficial CMs as well as high rebleed rates. (2) 
Treatment options include observation, 
and surgery, and a few authors in the past 
reported cases treated with radiosurgery but 
now it gained acceptance that radiosurgery has 
no positive long term impact in the treatment 
of cavernomas.  Especially superficial 
supratentorial  lesions with a low risk of 
bleeding and producing neurologic deficit can 
be followed by observation alone but this 
approach is not safe for patients harboring 
deep seated lesions prone to produce new 
neurological deficits in case of rerupture. Most 
of the studies report good outcomes with almost 
100% complete removal, though this is not the 
case in the posterior fossa where the post-
operative morbidity can be as high as 30%. (4) 
Materials and methods 
The objectives of the study were to analyze 
the the factors that influence the short and 
long term outcome, to establish the best 
indications for surgery and to define the safe 
corridors to approach deep seated lesions.  We 
retrospectively reviewed the clinical records 
the surgical details and the acute and delayed 
surgical complications for 130 consecutive 
patients operated between January 2000 and 
December 2009 in our department. The 
average follow up was around 5 years (between 
6 months and 10 years). All the patients were 
investigated with CT scan and MRI as the 
cavernomas are angiographically occult 
lesions. The outcome was evaluated 
comparing preoperative with postoperative 
modified Rankin Scale (mRS). 
The senior surgeon (R.M.G) did not feel 
the need to use neuronavigation or of 
Stereotaxy for locating the lesions nor for 
those located immediately subcortical or for 
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those in deep locations. We did not use motor, 
sensitive or cranial nerves evoked potentials. 
Based on the information from the MRI the 
surgical approach was directed on the shortest 
way to the lesion. The indication  for  surgery 
depends on the clinical state of the patient , for 
the supratentorial location either repeated 
seizures, motor or sensory deficit if the 
internal capsule or the thalamus are injured or 
visual disturbance if the optic radiations are 
injured. (20, 22) As the natural course of the 
brainstem cavernomas is more aggressive than 
of those located supratentorial and the risk of 
clinical significant hemorrhage is higher 
surgical resection is indicated in all 
symptomatic and accessible lesions. Even if 
some studies report a 30% risk of new 
neurological deficit after surgery these make 
often a significant clinical recovery and there 
is no risk of rebleeding. (6, 8, 14) 
In almost all subcortical and deep seated 
supratentorial lesions the approach was 
transcortical with care not to injure eloquent 
areas or important veins, but respecting the 
rule of the shortest way to the lesion. The 
approaches used for the infratentorial lesions 
including those of the brainstem were 
retrosigmoid, supracerebelar infratentorial, 
suboccipital and suboccipital telovelar.  All the 
lesions were approached from the point where 
they came closest to the surface (the 2 point 
method). (26, 27) 
The microsurgical technique included 
sharp dissection and piecemeal resection or 
one piece resection where possible in more 
superficial lesions. Except for the deep seated 
lesions the surrounding hemosiderin rich 
gliotic ring was also removed, but the 
associated venous anomalies where it was the 
case were all left untouched. 
In cases with multiple cavernomas surgery 
is indicated for the lesions responsible for 
neurological deficit, the other lesions are just 
imagistically followed. (7) 
Results 
Between 2000 and 2009 130 consecutive 
patients with cavernomas were operated in our 
department. The mean age at presentation was 
43,64 years range between 17 and 76. 
The 130 operated cases were divided into a 
supratentorial 102 (78.46%) group and an 
infratantorial group 28 (21.53%). The average 
age at presentation was 43,62 years old (17-76) 
and there was no sex predominance, 
male/female = 1,44 (77/53). Only in 14 cases 
(10.76%) we could find multiple cavernomas 
which had relatives with multiple cavrnomas, 
but the familial inheritance was not studied, 
but only the symptomatic lesion was resected. 
The supratentorial cavernomas were 
located in frontal lobes in 52 patients (40%), in 
temporal lobes in 27 patients (20.76%) in 
parietal lobes in 25 patients (19,23%) in 
occipital lobes in 2 patients (1,53%) and deep 
in 24 (18,46%) 
The infratentorial cavernomas were 
distributed in cerebellum 15 patients (53.57%), 
and in brainstem and cerebellar peduncles in 
13 patients (46,42%). Out of these 13 patients, 
3 were in medulla, 2 in the pontomedullary 
junction 4 in the pons and 4 in the 
mesencephalus.  
The clinical presentation was differentin 
the two groups:  in the supratentorial one, 
seizures and headache while the dominant 
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symptoms but in the infratentorial group 
where the cranial nerve deficits, hemiparesis, 
numbness and cerebellar syndrome were 
dominant (Table 1). 
Hemorrhage was present on MRI in 40 
patients (30.76%) in 38 (95%) as 
intraparenchymal hematoma, in 1 patient as 
intraventricular bleeding and in 1 as 
subarachnoid hemorrhage. 31 of these patients 
(77.5%) were in a poor preoperative mRS, 
having an altered mental state. 
The patients with seizures 66 p (50.76%) 
were stratified according to type and 
frequency (Table 2). 
 
TABLE I 
Supratentorial cavernomas 
Hemorrhage Seizures Headache Hemiparesis Numness Aphasia Visual deficits 
29/102 (28,43%) 66/102 
(64.70%) 
58/102 
(56,86%) 
19/102 
(18,62%) 
19/102 
(18,62%) 
13/102 
(12.74%) 
3/102 (2.94%) 
Infratentorial cavernomas 
hemorrhage Cranial nerve deficits headache hemiparesis numbness Cerebellar syndrome 
14/28  (50%) 15/28 (53,57%) 13/28 (46,42%) 11/28 
(39,28%) 
11/28 
(39,28%) 
9/28 (32.14%) 
 
TABLE II 
Type 
• Generalized tonic-clonic seizures – 32 p (48.48%) 
• Partial complexe seizures – 24 p (36,36% ) 
• Partial simple seizures – 15 p (22.72%) 
• Partial seizure, secondary generalized – 9 p (13.63%) 
• * some patients presented more than one type of seizures 
Frequency  
• 1-2 seizures before surgery – 30 p (45,45%)  
• 1-2 seizures/year – 17 (25,75%) 
• 1 seizure/week – 9 (13.63%) 
• daily seizures – 11 (16.66%) 
 
11 p (16.66%) presented refractory seizures  
Mean time between seizure onset and surgery = 4 mo (0.4 → 40 mo) 
 
Based on this data we identified a few risk factors for seizure reccurence. There were no seizures 
in deep locations. 
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TABLE III 
Risk factors for seizures occurrence: 
• Cortical location 
• T location, especially temporomesial location 
• Large lesions, including hemosiderinic ring     
• Focal neurological deficits 
• Left side cavernomas  
• Acute hemorrhage  
• Subacute hemorrhage  
• Surrounding edema* 
were not confirmed as risk factors for seizures occurrence 
• Sex,  
• age,  
• diameter of hemosiderinic ring,  
• diameter of surrounding edema, 
•  multiple lesions  
 
Outcome 
When we analyzed the outcome we studied 
the group of corticalised or superficial 
subcortical cavernomas and that of deep 
seated lesions, in brainstem, thalamus and 
basal ganglia. 
Total resection was performed in all cases, 
but the surrounding hemosiderin ring was not 
removed in deep seated lesions where such a 
maneuver could harm grey matter nuclei and 
no mortality was registered on short or long 
term follow up in this series of 130 patients. 
 Both Karnovsky and mRS improved after 
surgery. In patients with deep seated lesions 
(37 patients), 12 (32,43%) presented in a poor 
preoperative state mRS > 2. 10 patients from 
this group had  worsened deficits immediately 
after surgery, 4 of these in brainstem 
cavernomas but all of them showed a good 
recovery with follow up 5 of them remained in 
mRS 2 and 3 with mRS>2.  The complications 
included worsened hemiparesis, worsened 
ataxia, 7th nerve paresis and VI or IIIrd nerve 
paresis. 
The immediate postoperative status for this 
group was excellent in 10/37 (27,02%) of 
patients, good in 13/37 (35,13%) patients and 
poor in 14 (37,83%) patients. The long term 
follow up for these patients showed that 31/37 
(83,78%) of patients had a mRS between 0 and 
2, and the rest had a poor long term outcome. 
The situation was different in the group of 
superficial cavernomas where 55/93 (59.13%) 
of patients presented with a mRS of 0 or 1 and 
36/93 (38,7%) presented with mRS of 2 and 2 
patients with an mRS>2.  
After surgery there was no clinical 
deterioration in this group and 22 patients 
from those who presented in mRS 2 showed 
neurological improvement on long term 
follow up, meaning that 82,79% of patients had 
a 0 or 1 mRS. 
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Case presentations 
Case 1: A 70 years old male was admitted 
for persistent headache and left homonymous 
hemianopsia that worsened in the week 
previous presentation. 
 
 
 
 
Figure 1 - MRI – right occipital heterogenous lesion, 
with salt and pepper appearance suggestive for 
cavernoma 
The tumor was completely removed with 
the surrounding hemosiderin ring using a 
right suboccipital occipital-supratentorial 
approach. Using the gravity with no need for 
mechanical retraction, the lesion was exposed 
corticalised on the tentorial surface of the right 
occipital lobe. The tumor was piecemeal 
removed and then the hemosiderin ring was 
resected. Hemostasis was achieved with 
bipolar and intensive lavage with serum. After 
the dural closure the scalp is closed on epidural 
drain.  The postoperative CT scan confirmed 
complete removal. 
 
 
 
Figure 2 - Same patient with postop CT images of the 
occipital cavernoma – total removal 
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Case 2: A 45 years old female presented 
with altered mental state (14 p) and a history 
of headache, vomiting, swallowing disorders 
(liquid and solid food), gait disturbances 
(astasia-abasia), mild right faciobrachial 
paresis with onset 7 days before admission. 
The Neurologic exam showed mild right 
faciobrachial paresis and IX, X, XI and XII 
cranial nerves paresis. 
 
 
 
Figure 3 - CT scan - spontaneous hyperdense lesion 
within the right medulla, Ø = 13 mm 
 
 
 
 
Figure 4 - MRI: right medulla lesion, H-iso in T1 and h-HT2, 
Ø = 13 mm, suggestive for cavernoma, with subacute bleeding 
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The lesion was completely resected using a 
telovelar approach. A midline suboccipital 
craniectomy was performed, and after opening 
the cisterna magna a telovellar approach is 
used to access the medulla. As the lesion 
appeared subpial it was entered directly and 
then piecemeal resected completely. The 
surrounding yellow gliotic plane was left 
intact. Dura mater was reconstructed with 
Kolagen and then with the drain left in place 
the muscles plane and the skin were closed.  
The outcome was favorable with partial 
remission of the cranial nerves deficits and 
improvement of swallowing disorders at 2 
months follow up. (Figure 4) 
 
 
 
 
Figure 5 - Postop. MRI with complete resection of the 
cavernoma 
Discussions 
The frequency of asymptomatic 
cavernomas can be as high as 40% 
(Zabramsky), but the actual data is impossible 
to quantify. 
The most common presenting symptoms 
for the supratentorial group were seizures, 
headache, hemiparesis and numbnes. The 
most common infratentorial presentation 
were cranial nerve deficits followed by 
hemiparesis and numbness and cerebellar 
symptoms. 
Compared to the infratentorial group 
where the hemorrhagic presentation was 
almost the rule (93%) only 39% of the 
supratentorial group patients had this 
presentation.  
The division into supratentorial and 
infratentorial groups is not enough and 
further studies should focus on the differences 
of the groups of patients with cortical or 
subcortical cavernomas compared to those 
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with cavernomas seated in brainstem, 
thalamus or basal ganglia. (1, 3) 
The best method for preoperative and 
postoperative investigating the patient is the 
MRI. It can show the borders of the lesion the 
intra or extralesional hemorrhage and the 
associated edema and also is invaluable in 
planning the aproach especially if 
neuronavigation or stereotaxy are not used for 
localization. Angiography can be useful in 
defining associated lesions because 
cavernomas are not visible on it but we did not 
make a standard from using it and this may be 
a reason why venous associated anomalies 
escaped our view.  
 As cavernomas in deep locations have an 
annual hemorrhage rate of 5,1% and a rebleed 
rate of 31,5% per patient per year, there was no 
time for wait and see in these cases. 
Observation was reserved only to those cases 
we considered inoperable. Complete removal 
was achieved in all cases but with the cost of 
new neurological deficits in 4 patients (3%), all 
of these presenting deep seated lesions. The 
postoperative mRS was good or excellent in 
97% of patients compared to 64% preoperative 
and was even more evident in patients with 
deep seated lesions. The control of the seizures 
was achieved in all patients who presented 
with seizures, and almost 60% of them were 
free of medication after surgery. 
The dimensions of the lesions were not 
statistically different in the two groups but in 
the infratentorial group they correlated with 
the hemorrhage and neurologic deficit. Some 
studies report larger sizes of cavernomas in 
children but our study included only adults. 
We could find an association with venous 
anomalies only in 3 patients which is in 
contrast to the reports of other studies. 
As prospective studies are lacking the 
hemorrhage rates which are the key to the 
surgical indication are calculated based on 
retrospective analysis considering cavernomas 
as congenital lesions, yet more and more 
studies document the appearance of de novo 
cavernomas in sporadic or familial cases.  Even 
the results of different studies differ it became 
clear that once symptomatic the cavernomas 
have a high rate of rebleeding causing new 
neurological deficits. (14, 18, 19) 
Because of their tendency to bleed 
cavernomas are always in the surgical focus, 
yet surgery should not be proposed for all 
lesions, most of the supratentorial lesions can 
be treated conservatively if asymptomatic. 
Most of the time the hemorrhage is inside the 
cavrnoma causing it’s enlargement in time, but 
when seated in deep nuclei even this 
enlargement can give neurological deficit, 
acting as a mass effect. When located in 
eloquent areas even small hemorrhage outside 
the lesion can be echoed in severe deficits. (11, 
12) 
Our study aimed at identifying those 
lesions with a higher tendency to produce 
deficits for which surgery is the best and the 
safest treatment but as is the case with many 
studies on cavernomas it is limited by its 
retrospective nature.  
As The most frequent manifestations of 
supratentorial lesions are repeated seizures, 
which disturb the patient’s life balance we 
identified a few risk factors for seizures like the 
cortical and more frequently the 
temporomesial location, the large cavernomas, 
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the location in the left hemisphere, the acute or 
subacute hemorrhage and edema. In all 
supratentorial lesions we removed the 
hemosiderin ring as well and we believe this is 
one of the main reasons for the complete 
disappearance of seizures in most of the cases. 
(23, 24) 
We identified a few positive prognostic 
factors including a high preoperative 
Karnofsky score   coincident with a mRS of 0 
or 1, the small size and the superficial location 
of the lesion.  
We did not consider radiosurgery an 
alternative to deep seated lesions because we 
considered the high rates of rebleeding after 
radiosurgery inacceptable and many studies 
showed that cavernomas can occur after 
radiation therapy. (12) 
Conclusions  
Symptomatic deep cavernous 
malformations in the brainstem, basal ganglia, 
and thalamus have a high bleed and rebleed 
rate and an aggressive natural history. Early 
surgery provides excellent clinical results and 
protects against future hemorrhages. 
Microsurgery is the treatment of choice in 
symptomatic brain cavernomas, total 
resection being the only curative treatment, 
capable to prevent further bleeding and to 
offer an efficient control of seizures.  
Complete cavernoma resection and 
resection of surrounding hemosiderin is 
recommended except for cavernomas located 
in the brainstem or in eloquent areas 
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